
IndraLab
Statements
reach
"There were several publications that indicated that luteolin, luteoloside, and apigenin inhibited NLRP3 activation in rodents (Fan et al., 2014; Lv et al., 2019; Wang, X. et al., 2021); however, to the best of our knowledge, the present study is the first research that investigates the involvement of NLRP3 inhibition in the anti-gouty arthritis effects of luteolin, luteoloside, and apigenin."
eidos
"There were several publications that indicated that luteolin , luteoloside , and apigenin inhibited NLRP3 activation in rodents ( Fan et al ., 2014 ; Lv et al ., 2019 ; Wang , X. et al ., 2021 ) ; however , to the best of our knowledge , the present study is the first research that investigates the involvement of NLRP3 inhibition in the anti-gouty arthritis effects of luteolin , luteoloside , and apigenin ."
eidos
"Using a 3-dimensional cell co-culture system , we further demonstrated that luteolin could efficiently suppress NLRP3 expression via disruption of IL-17A signaling in inflamed colon tissue , which also indicates the pharmacological potential of luteolin and wedelolactone in treating IBD ."